Open access
Open access
Powered by Google Translator Translator

RCT: In patients with cirrhosis treated with TIPS, prophylactic rifaximin reduced the risk for Hepatic Encephalopathy

7 Feb, 2021 | 21:10h | UTC

The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt: A Randomized Controlled Trial – Annals of Internal Medicine (link to abstract – $ for full-text)

Commentary: Rifaximin prevents overt hepatic encephalopathy after TIPS – HealthDay


Commentary on Twitter


Stay Updated in Your Specialty

No spam, just news.